MAPT and Alzheimer disease: Studies of patients with dominantly inherited Alzheimer’s disease have demonstrated that amyloid-beta and tau accumulate for many years before pathologic changes in memory and executive function1,2, and Aβ levels peak around the time clinical symptoms manifest3.